Integra LifeSciences | IART - 资产



金融业
股票价格
USD
资产
USD 3.58B
现金及等价物
USD 236.81M
销售成本
USD 178.71M
流动资产
USD 1.17B
流动负债
USD 346.85M
债务
USD 2.04B
EBIT
USD 11.47M
EBITDA
USD 76.18M
员工
4.4K
EPS每股收益
USD 0.54
股本和储备
USD 1.04B
销售毛利
USD 213.21M
债务利息支出
USD 22.47M
利息收入
USD 4.11M
贷款资金
USD 1.83B
市值
USD 1.34B
净收入
USD -4.62M
营业费用
USD 1.04B
营业利润
USD 11.47M
普通股股本
USD 77.82M
PE价格收益
5.07
税前利润
USD -2.41M
销售收入
USD 391.9M
销售和管理费用
USD 178.24M
股票
USD 495.04M
贸易债权人
USD 87.95M
应收帐款人
USD 264.41M


资产 更改 日
Abbott USD 110.43B 23.72B 2026-03
AtriCure USD 643.99M 10.19M 2026-03
Baxter International USD 19.85B 209M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Boston Scientific USD 44.35B 678M 2026-03
CONMED USD 2.31B 10.81M 2026-03
Cooper Companies USD 12.48B 58.1M 2026-03
Dexcom USD 6.63B 293.4M 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
Globus Medical USD 5.44B 136.79M 2026-03
HeartBeam USD 3.93M 1.91M 2026-03
Insulet USD 2.99B 203.2M 2026-03
Integra LifeSciences USD 3.58B 24.28M 2026-03
Intuitive Surgical USD 20.11B 347.7M 2026-03
J&J USD 200.89B 1.68B 2026-03
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.72B 33.36M 2026-03
Orthofix International USD 886.6M 35.95M 2026-03
Smith & Nephew USD 10.69B 150M 2025-12
Stryker USD 46.29B 1.55B 2026-03
Tandem Diabetes Care USD 1.15B 272.28M 2026-03
Teleflex USD 6.78B 164.24M 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03